Citius Pharmaceuticals Inc. Common (CTXR) is a publicly traded Healthcare sector company. As of May 21, 2026, CTXR trades at $0.57 with a market cap of $14.47M and a P/E ratio of -0.26. CTXR moved +4.31% today. Year to date, CTXR is -38.29%; over the trailing twelve months it is -21.47%. Its 52-week range spans $0.48 to $13.52. Rallies surfaces CTXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CTXR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CTXR recently traded at $0.57. Market cap is $14.47M. P/E ratio is -0.26. Revenue is $5.61M.
| Metric | Value |
|---|---|
| Price | $0.57 |
| Market Cap | $14.47M |
| P/E Ratio | -0.26 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.52 |
| 52-Week Low | $0.48 |
| Volume | 4.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.61M |
| Net Income | $-55.45M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-39.74M | $-3.38 |
| 2024 | $0 | $-39.43M | $-5.97 |
| 2023 | $0 | $-32.54M | $0.00 |
| 2022 | $0 | $-33.64M | $-0.23 |
CTXR analyst coverage data. Average price target: $0.00.